Monkey pox. IV. Modification of disease pattern by antilymphocytic sera.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000494:pharmacology; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D007106:Immune Sera / Q000494:pharmacology*; D007273:Injections, Intramuscular; D008198:Lymph Nodes / Q000473:pathology; D008214:Lymphocytes; D008221:Lymphoid Tissue / Q000473:pathology; D011212:Poxviridae / Q000187:drug effects* / Q000302:isolation & purification; D011213:Poxviridae Infections / Q000473:pathology*; D012867:Skin / Q000473:pathology; D013154:Spleen / Q000473:pathology
D000906:Antibodies; D000961:Antilymphocyte Serum; D007106:Immune Sera